73 related articles for article (PubMed ID: 9022598)
1. Neuroendocrine mechanism of anovulation in users of contraceptive subdermal implant of nomegestrol acetate (Uniplant).
Barnhart K; Devoto L; Pommer R; Sir-Pettermann T; Robinovic J; Coutinho E
Fertil Steril; 1997 Feb; 67(2):250-5. PubMed ID: 9022598
[TBL] [Abstract][Full Text] [Related]
2. Temporal relationship between Uniplant insertion and changes in cervical mucus.
Barbosa IC; Coutinho E; Hirsch C; Ladipo OA; Olsson SE; Ulmsten U
Contraception; 1996 Oct; 54(4):213-7. PubMed ID: 8922874
[TBL] [Abstract][Full Text] [Related]
3. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
Barbosa I; Coutinho E; Hirsch C; Ladipo O; Olsson SE; Ulmsten U
Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629
[TBL] [Abstract][Full Text] [Related]
4. Changes in the menstrual bleeding of users of a subdermal contraceptive implant of nomegestrol acetate (Uniplant) do not influence sexual frequency, sexual desire, or sexual enjoyment.
Barnhart KT; Furman I; Pommer R; Coutinho E; Devoto L
Fertil Steril; 1997 Feb; 67(2):244-9. PubMed ID: 9022597
[TBL] [Abstract][Full Text] [Related]
5. Hormonal profile, endometrial histology and ovarian ultrasound assessment during 1 year of nomegestrol acetate implant (Uniplant).
Devoto L; Kohen P; Barnhart K; Alba F; Pommer R; Retamales I; Coutinho E
Hum Reprod; 1997 Apr; 12(4):708-13. PubMed ID: 9159430
[TBL] [Abstract][Full Text] [Related]
6. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
7. Androgen levels in women using a single implant of nomegestrol acetate.
Barbosa I; Coutinho E; Athayde C; Ladipo OA; Olsson SE; Ulmsten U
Contraception; 1996 Jan; 53(1):37-40. PubMed ID: 8631188
[TBL] [Abstract][Full Text] [Related]
8. Effect of preovulatory insertion of Norplant implants over luteinizing hormone secretion and follicular development.
Brache V; Alvarez F; Faundes A; Cochon L; Thevenin F
Fertil Steril; 1996 Jun; 65(6):1110-4. PubMed ID: 8641481
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic and endocrine evaluation of ovarian function among Norplant implants users with regular menses.
Alvarez F; Brache V; Faundes A; Tejada AS; Thevenin F
Contraception; 1996 Nov; 54(5):275-9. PubMed ID: 8934060
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive potential of a mifepristone-nomegestrol acetate sequential regimen in women.
Croxatto HB; Salvatierra AM; Fuentealba B; Massai R
Hum Reprod; 1998 Dec; 13(12):3297-302. PubMed ID: 9886502
[TBL] [Abstract][Full Text] [Related]
11. Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel.
Davies GC; Feng LX; Newton JR; Van Beek A; Coelingh-Bennink HJ
Contraception; 1993 Mar; 47(3):251-61. PubMed ID: 8462316
[TBL] [Abstract][Full Text] [Related]
12. Effects of a single Silastic contraceptive implant containing nomegestrol acetate (Uniplant) on endometrial morphology and ovarian function for 1 year.
Barbosa IC; Maia H; Coutinho E; Lopes R; Lopes AC; Noronha C; Botto A
Contraception; 2006 Dec; 74(6):492-7. PubMed ID: 17157108
[TBL] [Abstract][Full Text] [Related]
13. Response to intermittent RU486 in women.
Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
[TBL] [Abstract][Full Text] [Related]
14. The use of nomegestrol acetate subdermal contraceptive implant, uniplant, during lactation.
Abdel-Aleem H; Abol-Oyoun el-S M; Shaaban MM; el-Saeed M; Shoukry M; Makhlouf A; Salem HT
Contraception; 1996 Nov; 54(5):281-6. PubMed ID: 8934061
[TBL] [Abstract][Full Text] [Related]
15. [Antigonadotropic effects of a 19-nor-progesterone derivative: the example of nomegestrol acetate].
Jamin C; Batallan A; Madelenat P
Gynecol Obstet Fertil; 2003 Jan; 31(1):70-81. PubMed ID: 12659788
[TBL] [Abstract][Full Text] [Related]
16. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 2. Maintenance of ovarian function in patients with megestrol acetate implants.
Benagiano G; Ermini M; Carenza L; Donini P
Acta Endocrinol (Copenh); 1973 Jun; 73(2):347-59. PubMed ID: 4740834
[TBL] [Abstract][Full Text] [Related]
17. Multicenter clinical trial on the efficacy and acceptability of a single contraceptive implant of nomegestrol acetate, Uniplant.
Coutinho EM; de Souza JC; Athayde C; Barbosa IC; Alvarez F; Brache V; Gu ZP; Emuveyan EE; Adekunle AO; Devoto L; Shaaban MM; Salem HT; Affandi B; de Acosta OM; Mati J; Ladipo OA
Contraception; 1996 Feb; 53(2):121-5. PubMed ID: 8838490
[TBL] [Abstract][Full Text] [Related]
18. Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary-ovarian function in women.
Bazin B; Thevenot R; Bursaux C; Paris J
Br J Obstet Gynaecol; 1987 Dec; 94(12):1199-204. PubMed ID: 3122820
[TBL] [Abstract][Full Text] [Related]
19. The effects of nomegestrol acetate subdermal implant (Uniplant) on carbohydrate metabolism, serum lipoproteins and on hepatic function in women.
Barbosa I; Coutinho E; Athayde C; Ladipo O; Olsson SE; Ulmsten U
Contraception; 1995 Aug; 52(2):111-4. PubMed ID: 8536447
[TBL] [Abstract][Full Text] [Related]
20. One year contraception with a single subdermal implant containing nomegestrol acetate (Uniplant).
Coutinho EM
Contraception; 1993 Jan; 47(1):97-105. PubMed ID: 8436005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
